Anderton BH - Search Results

1

Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.

Lantos PL, Luthert PJ, Hanger D, Anderton BH, Mullan M, Rossor M. Lantos PL, et al. Among authors: anderton bh. Neurosci Lett. 1992 Mar 30;137(2):221-4. doi: 10.1016/0304-3940(92)90408-y. Neurosci Lett. 1992. PMID: 1584463

2

Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia.

Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN. Wightman G, et al. Among authors: anderton bh. Neurosci Lett. 1992 May 25;139(2):269-74. doi: 10.1016/0304-3940(92)90569-s. Neurosci Lett. 1992. PMID: 1376881

3

Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein.

Hanger DP, Mann DM, Neary D, Anderton BH. Hanger DP, et al. Among authors: anderton bh. Biochem Soc Trans. 1992 Aug;20(3):642-5. doi: 10.1042/bst0200642. Biochem Soc Trans. 1992. PMID: 1426605 Review. No abstract available.

4

Tau pathology in a case of familial Alzheimer's disease with a valine to glycine mutation at position 717 in the amyloid precursor protein.

Hanger DP, Mann DM, Neary D, Anderton BH. Hanger DP, et al. Among authors: anderton bh. Neurosci Lett. 1992 Oct 12;145(2):178-80. doi: 10.1016/0304-3940(92)90016-z. Neurosci Lett. 1992. PMID: 1465214

5

Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.

Hanger DP, Brion JP, Gallo JM, Cairns NJ, Luthert PJ, Anderton BH. Hanger DP, et al. Among authors: anderton bh. Biochem J. 1991 Apr 1;275 ( Pt 1)(Pt 1):99-104. doi: 10.1042/bj2750099. Biochem J. 1991. PMID: 1826835 Free PMC article.

6

Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome.

Spargo E, Luthert PJ, Anderton BH, Bruce M, Smith D, Lantos PL. Spargo E, et al. Among authors: anderton bh. Neurosci Lett. 1990 Jul 31;115(2-3):345-50. doi: 10.1016/0304-3940(90)90480-w. Neurosci Lett. 1990. PMID: 2146532

7

PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta.

Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP. Mulot SF, et al. Among authors: anderton bh. FEBS Lett. 1994 Aug 8;349(3):359-64. doi: 10.1016/0014-5793(94)00702-0. FEBS Lett. 1994. PMID: 8050597 Free article.

8

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL. Cairns NJ, et al. Among authors: anderton bh. Neurosci Lett. 1997 Jul 11;230(1):49-52. doi: 10.1016/s0304-3940(97)00474-6. Neurosci Lett. 1997. PMID: 9259461

9

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. Hanger DP, et al. Among authors: anderton bh. Neurosci Lett. 1992 Nov 23;147(1):58-62. doi: 10.1016/0304-3940(92)90774-2. Neurosci Lett. 1992. PMID: 1336152

10

Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease.

Noble W, Garwood C, Stephenson J, Kinsey AM, Hanger DP, Anderton BH. Noble W, et al. Among authors: anderton bh. FASEB J. 2009 Mar;23(3):739-50. doi: 10.1096/fj.08-113795. Epub 2008 Nov 11. FASEB J. 2009. PMID: 19001528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters